Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO Cash from Financing (Quarterly): -0.854M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.854M |
September 30, 2023 | 6.343M |
June 30, 2023 | -0.674M |
March 31, 2023 | -2.473M |
December 31, 2022 | 4.16M |
September 30, 2022 | -2.068M |
June 30, 2022 | -0.166M |
March 31, 2022 | -0.153M |
December 31, 2021 | -0.196M |
September 30, 2021 | -1.255M |
June 30, 2021 | 31.98M |
March 31, 2021 | -10.64M |
December 31, 2020 | 1.586M |
September 30, 2020 | -0.082M |
June 30, 2020 | 3.665M |
March 31, 2020 | -1.021M |
December 31, 2019 | -16.20M |
September 30, 2019 | 1.403M |
June 30, 2019 | -4.202M |
March 31, 2019 | 34.99M |
December 31, 2018 | 15.69M |
September 30, 2018 | 0.374M |
Date | Value |
---|---|
June 30, 2018 | 8.431M |
March 31, 2018 | 3.232M |
December 31, 2017 | 23.85M |
September 30, 2017 | -0.013M |
June 30, 2017 | 0.023M |
March 31, 2017 | |
December 31, 2016 | 40.49M |
September 30, 2016 | 9.643M |
June 30, 2016 | 3.615M |
March 31, 2016 | -2.073M |
December 31, 2015 | -8.491M |
September 30, 2015 | 7.039M |
June 30, 2015 | 48.32M |
March 31, 2015 | -0.125M |
December 31, 2014 | -0.003M |
September 30, 2014 | 0.00 |
June 30, 2014 | -0.1691M |
March 31, 2014 | 30.71M |
December 31, 2013 | 0.1408M |
September 30, 2013 | 0.27M |
June 30, 2013 | 0.3653M |
March 31, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-16.20M
Minimum
Dec 2019
31.98M
Maximum
Jun 2021
0.482M
Average
-0.196M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
XOMA Corp | -4.956M |
Ironwood Pharmaceuticals Inc | -15.56M |
CymaBay Therapeutics Inc (DELISTED) | 2.729M |
Homology Medicines Inc (DELISTED) | 0.014M |
Amgen Inc | -1.708B |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 1.527M |
Cash from Investing (Quarterly) | -0.734M |
Free Cash Flow | -9.242M |
Free Cash Flow Per Share (Quarterly) | 0.0076 |
Free Cash Flow to Equity (Quarterly) | 1.033M |
Free Cash Flow to Firm (Quarterly) | 3.37M |
Free Cash Flow Yield | -8.90% |